http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009174915-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_49f04b1dc6b9fcc2d8b159c5ebee364b |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-64 |
| filingDate | 2008-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_971b9e451bfc2e9f096fbaabe13ecd4c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90b17a532e5e2dd4dc68530a6fa110a8 |
| publicationDate | 2009-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2009174915-A |
| titleOfInvention | Disease determination method, disease determination device, disease determination data generation method, and disease determination data generation device |
| abstract | Disclosed is a disease determination method and a disease determination data generation method capable of more accurately determining a sample suspected of having a disease even if the determination method is simple and the disease state is mild. To do. The excitation light obtained by irradiating the biological sample with excitation light while continuously or intermittently changing the wavelength, and measuring the wavelength and intensity of the emitted light emitted from the biological sample. The three-dimensional light spectrum composed of the wavelength, the wavelength of the emitted light, and the intensity of the emitted light is based on the intensity of the emitted light in the range of the excitation light wavelength 280 nm to 370 nm and the emitted light wavelength 300 to 500 nm in the three-dimensional light spectrum. The evaluation value of the three-dimensional light spectrum based on a background classification step for classifying into one of a plurality of background groups and an evaluation function for evaluating the shape of the three-dimensional light spectrum, which is predetermined for each background group. An evaluation value acquisition step to be acquired; an attribute determination step for determining a disease attribute of the biological sample based on the evaluation value; and . [Selection] Figure 2 |
| priorityDate | 2008-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 19.